IL131200A - Benzofurazan compounds, pharmaceutical compositions comprising them and their use for the preparation of medicaments which enhance ampa receptor activity - Google Patents

Benzofurazan compounds, pharmaceutical compositions comprising them and their use for the preparation of medicaments which enhance ampa receptor activity

Info

Publication number
IL131200A
IL131200A IL13120098A IL13120098A IL131200A IL 131200 A IL131200 A IL 131200A IL 13120098 A IL13120098 A IL 13120098A IL 13120098 A IL13120098 A IL 13120098A IL 131200 A IL131200 A IL 131200A
Authority
IL
Israel
Prior art keywords
compounds
medicaments
preparation
ampa receptor
pharmaceutical compositions
Prior art date
Application number
IL13120098A
Other languages
English (en)
Other versions
IL131200A0 (en
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL131200A0 publication Critical patent/IL131200A0/xx
Publication of IL131200A publication Critical patent/IL131200A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Hydrogenated Pyridines (AREA)
  • Furan Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL13120098A 1997-02-13 1998-02-13 Benzofurazan compounds, pharmaceutical compositions comprising them and their use for the preparation of medicaments which enhance ampa receptor activity IL131200A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,108 US6110935A (en) 1997-02-13 1997-02-13 Benzofurazan compounds for enhancing glutamatergic synaptic responses
PCT/US1998/002713 WO1998035950A1 (fr) 1997-02-13 1998-02-13 Composes a base de benzofurazan renforçant l'activite du recepteur de l'ampa

Publications (2)

Publication Number Publication Date
IL131200A0 IL131200A0 (en) 2001-01-28
IL131200A true IL131200A (en) 2005-06-19

Family

ID=25177504

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13120098A IL131200A (en) 1997-02-13 1998-02-13 Benzofurazan compounds, pharmaceutical compositions comprising them and their use for the preparation of medicaments which enhance ampa receptor activity

Country Status (24)

Country Link
US (3) US6110935A (fr)
EP (2) EP0960105B1 (fr)
JP (1) JP4446023B2 (fr)
KR (1) KR100544295B1 (fr)
CN (1) CN1085206C (fr)
AT (2) ATE326221T1 (fr)
AU (1) AU737802C (fr)
BR (1) BR9807333B1 (fr)
CA (1) CA2279319C (fr)
CZ (1) CZ299765B6 (fr)
DE (2) DE69823803T2 (fr)
DK (2) DK0960105T3 (fr)
ES (2) ES2264078T3 (fr)
GB (1) GB2325225B (fr)
HU (1) HUP0002303A3 (fr)
ID (1) ID22342A (fr)
IL (1) IL131200A (fr)
NO (1) NO318935B1 (fr)
NZ (1) NZ336980A (fr)
PL (1) PL199135B1 (fr)
PT (2) PT960105E (fr)
RU (1) RU2189984C2 (fr)
TR (1) TR199901941T2 (fr)
WO (1) WO1998035950A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188837B (fr) 1998-05-22 2002-11-09 Torrent Pharmaceuticals Ltd
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
CA2509251A1 (fr) * 2003-01-13 2004-07-29 Cortex Pharmaceuticals, Inc. Methode de traitement du declin cognitif du au manque de sommeil et au stress
US7385061B2 (en) * 2003-05-23 2008-06-10 Basilea Pharmaceutica Ag Furazanobenzimidazoles
EP1715863B1 (fr) * 2004-01-26 2012-05-09 Cortex Pharmaceuticals, Inc. Renforcement de la facilitation induite par ampakine des reponses synaptiques par les inhibiteurs de la cholinesterase
JP2010501597A (ja) * 2006-08-31 2010-01-21 ザ ガバナーズ オブ ザ ユニバーシティー オブ アルバータ 正のアロステリックａｍｐａ受容体モジュレーターを用いて呼吸抑制を阻害する方法
AP2009004915A0 (en) * 2007-01-03 2009-08-31 Cortex Pharma Inc 3-substituted-[1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses
PL2144506T3 (pl) * 2007-01-03 2012-04-30 Servier Lab 3-podstawiony-[1,2,3]-benzotriazynon jako związek do wzmacniania odpowiedzi glutaminianergicznych
AU2008254960B2 (en) * 2007-05-17 2014-11-27 Cortex Pharmaceuticals, Inc. Di-substituted amides for enhancing glutamatergic synaptic responses
CN101896183B (zh) 2007-08-10 2013-11-27 科泰克斯药品公司 用于增强谷氨酸能突触反应的二环酰胺
US8119632B2 (en) 2007-08-10 2012-02-21 Cortex Pharmaceuticals, Inc. Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
US8071914B2 (en) * 2007-12-26 2011-12-06 Noboru Oshima Heating apparatus
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
MX2011008060A (es) * 2009-02-02 2011-09-09 Cortex Pharma Inc Derivados de amida biciclica para mejorar las respuestas sinapticas glutamatergicas.
WO2011109398A2 (fr) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Procédés et compositions pour le traitement du syndrome d'angelman et des troubles du spectre autistique
US20110257186A1 (en) * 2010-04-15 2011-10-20 Staubli Ursula V Compositions and methods for treating visual disorders
EP2801377B1 (fr) 2011-03-04 2019-08-07 The Regents of The University of California Hydrogen contenant des cellules pour la libération locale des facteurs de croissance pour favoriser la récupération motrice après un accident vasculaire cérébral
CN102633731B (zh) * 2012-03-13 2014-04-30 四川大学华西医院 6-喹喔啉甲酸酰胺化合物、制备方法和应用
KR101421032B1 (ko) * 2012-12-28 2014-07-22 주식회사 레고켐 바이오사이언스 (2-메틸-1-(3-메틸벤질)-1Ｈ-벤조[d]이미다졸-5일)(피페리딘-5-일)메탄온의 제조방법
CA2915405A1 (fr) 2013-06-13 2014-12-18 Veroscience Llc Compositions et methodes pour le traitement des troubles metaboliques
CN107286114B (zh) * 2016-04-13 2020-08-18 中国人民解放军军事医学科学院毒物药物研究所 Ampa受体增效剂的脑靶向前药及其医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981864A (en) * 1973-09-08 1976-09-21 Eisai Co., Ltd. 1,3-Benzodioxol derivatives
FR2499991A1 (fr) * 1981-02-19 1982-08-20 Sandoz Sa Nouveaux 2,1,3-benzothiadiazoles et 2,1,3-benzoxadiazoles, leur preparation et leur application comme medicaments
US4420485A (en) * 1982-09-29 1983-12-13 Hoechst-Roussel Pharmaceuticals Inc. 1'-[3-(1,2-Benzisoxazol-3-yl) proply]spiro[benzofuran-2(3H),3' or 4'-piperidines or 3'-pyrrolidines]
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
US5112824A (en) * 1989-12-08 1992-05-12 Merck & Co., Inc. Benzofuran compounds as class III antiarrhythmic agents
PT651746E (pt) * 1992-07-24 2002-09-30 Univ California Drogas que intensificam as respostas sinapticas mediadas por receptores de ampa
DK0709384T3 (da) * 1994-10-31 1999-08-23 Merck Patent Gmbh Benzylpiperidinderivater med høj affinitet til aminosyrereceptorers bindingssteder
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5985871A (en) 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response

Also Published As

Publication number Publication date
JP2001512459A (ja) 2001-08-21
DE69823803T2 (de) 2005-04-14
US6110935A (en) 2000-08-29
DE69823803D1 (de) 2004-06-17
DE69834590D1 (de) 2006-06-22
CA2279319A1 (fr) 1998-08-20
EP0960105B1 (fr) 2004-05-12
ES2221152T3 (es) 2004-12-16
GB2325225A (en) 1998-11-18
US20020055508A1 (en) 2002-05-09
BR9807333A (pt) 2000-04-18
DK1428534T3 (da) 2006-06-12
NO993768D0 (no) 1999-08-04
NO318935B1 (no) 2005-05-30
HUP0002303A3 (en) 2002-09-30
ATE326221T1 (de) 2006-06-15
AU737802C (en) 2005-05-12
AU6159998A (en) 1998-09-08
ID22342A (id) 1999-09-30
EP0960105A1 (fr) 1999-12-01
US6313115B1 (en) 2001-11-06
CZ279599A3 (cs) 2000-01-12
HUP0002303A2 (hu) 2001-04-28
CN1247534A (zh) 2000-03-15
WO1998035950A1 (fr) 1998-08-20
JP4446023B2 (ja) 2010-04-07
ES2264078T3 (es) 2006-12-16
DE69834590T2 (de) 2007-04-26
NO993768L (no) 1999-09-23
NZ336980A (en) 2000-08-25
IL131200A0 (en) 2001-01-28
RU2189984C2 (ru) 2002-09-27
PT960105E (pt) 2004-09-30
CA2279319C (fr) 2008-08-05
GB9809221D0 (fr) 1998-07-01
PL335058A1 (en) 2000-03-27
DK0960105T3 (da) 2004-08-30
EP1428534B1 (fr) 2006-05-17
KR20000071082A (ko) 2000-11-25
BR9807333B1 (pt) 2011-10-18
PL199135B1 (pl) 2008-08-29
GB2325225A8 (en) 1999-02-17
PT1428534E (pt) 2006-07-31
CZ299765B6 (cs) 2008-11-19
CN1085206C (zh) 2002-05-22
US6730677B2 (en) 2004-05-04
AU737802B2 (en) 2001-08-30
TR199901941T2 (xx) 1999-12-21
EP1428534A1 (fr) 2004-06-16
KR100544295B1 (ko) 2006-01-23
ATE266649T1 (de) 2004-05-15
GB2325225B (en) 1999-03-03

Similar Documents

Publication Publication Date Title
IL131200A (en) Benzofurazan compounds, pharmaceutical compositions comprising them and their use for the preparation of medicaments which enhance ampa receptor activity
MA28010A1 (fr) Derives de piperazine et leur utilisation comme agents therapeutiques
ATE229806T1 (de) Wirkstoff zur behandlung neurodegenerativer störungen
RU93058531A (ru) Фторалкоксибензиламинные производные азотсодержащих гетероциклов, фармацевтическая композиция, способ лечения
BR9106665A (pt) Derivados de quinuclidina
CA2293382A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents anti-inflammatoires
DE59509846D1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
IL136783A (en) Synaptic response enhancing benzoxazine compounds,their preparation and pharmaceutical compositions containing them
EE200100125A (et) TAN-1057 derivaadid
TR199903272T2 (xx) Ast�m kar��t� ila�lar�n yeni bile�imleri.
ATE10841T1 (de) Tricyclische thiazolyloxamidsaeuren und derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
BRPI0409683A (pt) 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos
ATE150019T1 (de) Beta-mercapto-propanamidderivate verwendbar zur behandlung kardiovaskularer krankheiten oder erkrankungen
MX9202389A (es) Compuestos oligomericos aromaticos utiles como imitadores de macromoleculas bioactivas
BR0015402A (pt) Derivados de ácido 15-hidroxieicosatetraenóico de cadeia Èmega modificada e métodos de seu uso para o tratamento de olho seco
DE69405901D1 (de) 2, 3-Dihydro-4(1H)-quinazolinone zu Magen-Darmtherapien
TH28200B (th) การใช้ (สูตร) il -อะโกนิสท์สำหรับรักษาการกลั้นปัสสาวะไม่อยู่

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees